{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:15:01Z","timestamp":1771521301654,"version":"3.50.1"},"reference-count":9,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,19]]},"DOI":"10.1182\/blood.2025031851","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:31:18Z","timestamp":1771518678000},"page":"804-806","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["A viral Achilles\u2019 heel for EBV-positive lymphomas"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-1395","authenticated-orcid":false,"given":"Robert","family":"Yarchoan","sequence":"first","affiliation":[{"name":"National Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Tosato","sequence":"additional","affiliation":[{"name":"National Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"8","key":"2026021911311306800_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.2025029771","article-title":"Withaferin A inhibits EBV-driven lymphomagenesis through multiple mechanisms, including EBNA1 degradation","volume":"147","author":"Stewart","year":"2026","journal-title":"Blood"},{"key":"2026021911311306800_bib2","doi-asserted-by":"crossref","first-page":"113602","DOI":"10.1016\/j.bcp.2019.08.004","article-title":"Withaferin A: from ayurvedic folk medicine to preclinical anti-cancer drug","volume":"173","author":"Hassannia","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"2026021911311306800_bib3","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"issue":"26","key":"2026021911311306800_bib4","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"issue":"26","key":"2026021911311306800_bib5","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1182\/blood-2010-11-317610","article-title":"High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy","volume":"117","author":"Uldrick","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2026021911311306800_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cncr.35110","article-title":"Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 study","volume":"130","author":"Rajdev","year":"2024","journal-title":"Cancer"},{"issue":"4","key":"2026021911311306800_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1200\/JCO.24.00640","article-title":"Cancer immunotherapy trials network 12: pembrolizumab in HIV-associated Kaposi sarcoma","volume":"43","author":"Lurain","year":"2025","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026021911311306800_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"2026021911311306800_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaim.2018.12.008","article-title":"Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: a phase I trial","volume":"11","author":"Pires","year":"2020","journal-title":"J Ayurveda Integr Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/8\/804\/2504816\/blood_bld-2025-031851-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/8\/804\/2504816\/blood_bld-2025-031851-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:31:20Z","timestamp":1771518680000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/8\/804\/566471\/A-viral-Achilles-heel-for-EBV-positive-lymphomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,2,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031851","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,19]]},"published":{"date-parts":[[2026,2,19]]}}}